Literature DB >> 10229130

Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy.

G De Luca1, A Lugaresi, C Iarlori, F Marzoli, A Di Iorio, D Gambi, A Uncini.   

Abstract

We have recently demonstrated that ConA-induced suppressor cell function is defective in chronic inflammatory demyelinating polyneuropathy (CIDP). To assess whether this defect plays a role in disease activity and its reversal is important in recovery, we studied modifications of ConA-induced suppressor cell function induced by prednisone and plasma exchange in 20 patients with CIDP. We found a significant increase towards normal of ConA-induced suppressor cell function after treatment in concurrence with clinical improvement. Induction of suppression, presumably through favorable modifications of the cytokine network or other humoral mediators, might be one, among others, of the mechanisms through which prednisone and plasma exchange are effective in CIDP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229130     DOI: 10.1016/s0165-5728(98)00266-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Can plasma exchange therapy induce regulatory T lymphocytes in multiple sclerosis patients?

Authors:  A Jamshidian; M Gharagozloo
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 2.  Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Man Mohan Mehndiratta; Avinash Chandra Singh
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

Review 3.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

4.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 5.  The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  J Neuroinflammation       Date:  2021-03-22       Impact factor: 8.322

Review 6.  Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Man Mohan Mehndiratta; Richard A C Hughes; Jane Pritchard
Journal:  Cochrane Database Syst Rev       Date:  2015-08-25

7.  Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders.

Authors:  Aiden Haghikia; Moritz Perrech; Bartosz Pula; Sabrina Ruhrmann; Anja Potthoff; Norbert H Brockmeyer; Susan Goelz; Heinz Wiendl; Hans Lindå; Tjalf Ziemssen; Sergio E Baranzini; Tor-Björn Käll; Dietmar Bengel; Tomas Olsson; Ralf Gold; Andrew Chan
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

8.  Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; B Mark Keegan; Jeffrey L Winters; David Astapenko; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  Neurol Res Int       Date:  2011-09-22

9.  Plasmapheresis in a patient with "refractory" urticarial vasculitis.

Authors:  Ozgur Kartal; Mustafa Gulec; Zafer Caliskaner; Oral Nevruz; Turker Cetin; Osman Sener
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-14       Impact factor: 5.764

Review 10.  Therapeutic apheresis in kidney transplantation: An updated review.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  World J Transplant       Date:  2019-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.